Skip to main content
Premium Trial:

Request an Annual Quote

PathoGenetix Contracts with Sparton for Microbial Genotyping System

NEW YORK (GenomeWeb News) – PathoGenetix said today that it has tapped Sparton to design and manufacture pre-commercial instruments for its Resolution Microbial Genotyping System for detecting microbial pathogens in food.

Under the agreement, Schaumburg Ill.-based Sparton will handle the design, building, and pilot production of a limited number of pre-commercial instruments for the Resolution system, which is set to be on the market in the fourth quarter of 2014.

The Resolution system, which will be used for safety testing for the food industry and for investigating food-borne outbreaks, is the first commercial application for PathoGenetix' Genome Sequence Scanning technology. The system enables pathogen serotype identification and strain typing within five hours, and the bacterial strain information it provides is comparable to pulsed field gel electrophoresis, the current standard for pathogen typing for foodborne illness responses.

Woburn, Mass.-based PathoGenetix said pre-commercial units of the system are undergoing testing and evaluation by government and food industry partners, and it has shipped a version to Marshfield Food Safety for independent testing and feedback.

Financial terms of the agreement were not disclosed.

Filed under

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.